Supply Chain

The pharma supply chain consists of all the partners involved in the drug manufacturing and distribution process, starting from raw materials and ending with patients. Here you will find a broad array of information about topics such as track and trace, serialization, and auditing/managing suppliers.

Articles

shutterstock_2467268685
Adhering to a tried-and-true set of best practices during the PPQ stage can prevent a drug approval from stalling out on the final lap.
Aging populations are straining pharma production — here’s what the industry should do
ADMs allow manufacturers to take charge of supply channels to boost efficiency and flexibility
Pharma manufacturers will need to change their approach if they want to prevent supply chain challenges from rolling over into the new year
It’s essential to examine where the industry stands in regulating drugs and the improvement areas from the dispenser to the patient level
Shutterstock 2226244467
A cohesive 2D barcode strategy can drive operational improvements across the pharma ecosystem
Pm2309 Hero 854x480 Supply
How the pandemic spurred a technology evolution for temperature-sensitive products
Shutterstock 645414946
How a robust third-party risk management solution can alleviate drug supply chain pressures
Shutterstock 2025641213
How artificial intelligence can streamline pharma procurement and supply chain management
Pm2304 Hero 854x480 Supply
Modern digital technologies can build in traceability from development to commercialization to optimize outcomes
sept-final
Hint: It’s not by raising prices
PM2209-HERO-575x327-Culture
How reducing technology-addressable vaccine barriers affects coverage rates
PM2209-HERO-575x327-Supply
What it will take to build resilient and sustainable supply chains for the future
PM2208-HERO-575x327-Supply
Optimal packaging and labeling solutions help ensure the delivery of safe, effective viral vector products
PM2208-HERO-575x327-Development
A new biomanufacturing era demands that suppliers and manufacturers partner to efficiently bring new therapies to market